Compare SB & BVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SB | BVS |
|---|---|---|
| Founded | 2007 | 2011 |
| Country | Monaco | United States |
| Employees | 1107 | N/A |
| Industry | Marine Transportation | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 682.2M | 716.8M |
| IPO Year | N/A | 2016 |
| Metric | SB | BVS |
|---|---|---|
| Price | $6.41 | $10.38 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 3 |
| Target Price | $6.00 | ★ $14.00 |
| AVG Volume (30 Days) | ★ 864.5K | 599.9K |
| Earning Date | 05-18-2026 | 05-06-2026 |
| Dividend Yield | ★ 3.03% | N/A |
| EPS Growth | N/A | ★ 163.46 |
| EPS | N/A | ★ 0.04 |
| Revenue | N/A | ★ $568,087,000.00 |
| Revenue This Year | $3.47 | $7.52 |
| Revenue Next Year | $3.61 | $7.06 |
| P/E Ratio | ★ $16.77 | $262.00 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $3.61 | $5.81 |
| 52 Week High | $7.38 | $11.25 |
| Indicator | SB | BVS |
|---|---|---|
| Relative Strength Index (RSI) | 44.51 | 65.38 |
| Support Level | $6.32 | $8.42 |
| Resistance Level | $6.63 | $11.00 |
| Average True Range (ATR) | 0.27 | 0.39 |
| MACD | -0.04 | 0.17 |
| Stochastic Oscillator | 23.44 | 98.01 |
Safe Bulkers Inc is an international provider of marine drybulk transportation services, transporting bulk cargoes, particularly coal, grain, and iron ore, along international shipping routes for consumers of marine drybulk transportation services. The company employs its vessels on both period time charters and spot time charters, according to the assessment of market conditions, with consumers of marine drybulk transportation services. The company generates almost all of its revenue from Time Charters.
Bioventus Inc is a medical device company focused on developing and commercializing products to relieve pain and address musculoskeletal conditions. The company operates through two reporting segments, U.S. and International, and its product portfolio is organized into three main business areas: Pain Treatments, Surgical Solutions, and Restorative Therapies, offering products such as hyaluronic acid injections for osteoarthritis, peripheral nerve stimulation devices, bone graft substitutes, and ultrasound-based fracture healing therapies.